AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home hLife Article
Article Link
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Commentary | Open Access

Enabling manufacture and access to advanced therapy medicinal products in low- and middle-income countries

Antonio Carlos Campos de Carvalho1,2( ), Camile Giaretta Sachetti2, Marco Aurélio Krieger2
Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
Oswaldo Cruz Foundation, Rio de Janeiro, Brazil
Show Author Information

References

【1】
【1】
 
 
Crossref Google Scholar
hLife
Volume 3 Issue 11,
November 2025
Pages 521-523
DOI: 10.1016/j.hlife.2025.07.001

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Cite this Report
Close
Close
Cite this article:
Campos de Carvalho AC, Sachetti CG, Krieger MA. Enabling manufacture and access to advanced therapy medicinal products in low- and middle-income countries. hLife, 2025, 3(11): 521-523. https://doi.org/10.1016/j.hlife.2025.07.001

289

Views

1

Crossref
Received: 06 May 2025
Revised: 02 July 2025
Accepted: 05 July 2025
Published: 01 November 2025
© 2025 The Author(s).

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).